We are excited to announce that Innovation Norway has approved our application for Commercialisation grant of NOK 750,000, for initial activities to build understanding of the clinical development path requirements of LevellorTM with the European Medicines Agency, and compile application for an initial clinical pilot study to be undertaken in Norway. We are excited to collaborate with Innovation Norway on these activities and also further future projects.
